Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer.
Dewi DL, Mohapatra SR, Blanco Cabañes S, Adam I, Somarribas Patterson LF, Berdel B, Kahloon M, Thürmann L, Loth S, Heilmann K, Weichenhan D, Mücke O, Heiland I, Wimberger P, Kuhlmann JD, Kellner KH, Schott S, Plass C, Platten M, Gerhäuser C, Trump S, Opitz CA. Dewi DL, et al. Oncoimmunology. 2017 Jan 3;6(2):e1274477. doi: 10.1080/2162402X.2016.1274477. eCollection 2017. Oncoimmunology. 2017. PMID: 28344890 Free PMC article.
Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation.
Adam I, Dewi DL, Mooiweer J, Sadik A, Mohapatra SR, Berdel B, Keil M, Sonner JK, Thedieck K, Rose AJ, Platten M, Heiland I, Trump S, Opitz CA. Adam I, et al. Among authors: dewi dl. Oncoimmunology. 2018 Sep 5;7(12):e1486353. doi: 10.1080/2162402X.2018.1486353. eCollection 2018. Oncoimmunology. 2018. PMID: 30524887 Free PMC article.
The therapeutic potential of targeting tryptophan catabolism in cancer.
Opitz CA, Somarribas Patterson LF, Mohapatra SR, Dewi DL, Sadik A, Platten M, Trump S. Opitz CA, et al. Among authors: dewi dl. Br J Cancer. 2020 Jan;122(1):30-44. doi: 10.1038/s41416-019-0664-6. Epub 2019 Dec 10. Br J Cancer. 2020. PMID: 31819194 Free PMC article. Review.
Effect of in vivo administration of reprogramming factors in the mouse liver.
Tomokuni A, Eguchi H, Hoshino H, Dewi DL, Nishikawa S, Kano Y, Miyoshi N, Tojo A, Kobayashi S, Gotoh N, Hinohara K, Fusaki N, Saito T, Suemizu H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Doki Y, Mori M, Ishii H, Nagano H. Tomokuni A, et al. Among authors: dewi dl. Oncol Lett. 2013 Aug;6(2):323-328. doi: 10.3892/ol.2013.1418. Epub 2013 Jun 20. Oncol Lett. 2013. PMID: 24137324 Free PMC article.
microRNA-based cancer cell reprogramming technology.
Nishikawa S, Ishii H, Haraguchi N, Kano Y, Fukusumi T, Ohta K, Ozaki M, Dewi DL, Sakai D, Satoh T, Nagano H, Doki Y, Mori M. Nishikawa S, et al. Among authors: dewi dl. Exp Ther Med. 2012 Jul;4(1):8-14. doi: 10.3892/etm.2012.558. Epub 2012 Apr 23. Exp Ther Med. 2012. PMID: 23060915 Free PMC article.
Transcriptomic study of dormant gastrointestinal cancer stem cells.
Nishikawa S, Dewi DL, Ishii H, Konno M, Haraguchi N, Kano Y, Fukusumi T, Ohta K, Noguchi Y, Ozaki M, Sakai D, Satoh T, Doki Y, Mori M. Nishikawa S, et al. Among authors: dewi dl. Int J Oncol. 2012 Sep;41(3):979-84. doi: 10.3892/ijo.2012.1531. Epub 2012 Jun 25. Int J Oncol. 2012. PMID: 22735680
13 results